Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Brello Health vs Kongo

By GLP-1 ScorecardUpdated

Brello Health
Site position #373

Lower score

KongoFactor scores not reassessed.
Site position #19

Higher score

Score comparison

Kongo has the higher recorded score — 83.8/100 to 59.4/100.

Kongo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded injection plans with written support; confirm the charge, supplied quantity and renewal terms.

Before you choose

Before comparing the headline prices, the Brello Health review and the Kongo review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Brello Health vs NuviaRx and Care Clinics vs Kongo compare each of them with another graded program, and the list of alternatives to Brello Health ranks the programs closest to Brello Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueKongo +41
45
86
Dose & formulationKongo +16
64
80
Clinical oversightKongo +12
72
84
Labs & monitoringKongo +29
53
82
FulfillmentKongo +14
73
87
Contract termsKongo +32
53
85
Brello Health · top barKongo · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBrello HealthKongo
WeighScore59.4/10083.8/100
GradeCB
Site position#373#19
Semaglutide$399 per advertised 3-month supply; renews every 11 weeks ($133/mo equivalent)$109 one-month plan or $285 every three months advertised; confirm selected charge and supply.
Tirzepatide$499 per advertised 3-month supply, every 11 weeks; $894 per 6-month supply, every 22 weeks$209 one-month or $387 three-month plan advertised; confirm selected charge and supply.
CoverageCheck state availabilityAll 50 advertised; confirm treatment-specific state availability.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Brello Health

Site position #373 · C

Strengths

  • Publicly lists both compounded medication programs
  • Plans include fitness and nutrition classes plus support

What to consider

  • Multi-month upfront purchase
  • Three-month plans renew every eleven weeks, not a calendar quarter
  • Published post-approval refund instructions differ on deadline and contact method
Kongo

Site position #19 · B

Factor scores not reassessed.

Strengths

  • Regular one-month and prepaid totals published
  • Medication, care, supplies and shipping advertised included
  • Portal cancellation and clinical messaging

What to consider

  • Refund and refill cutoffs need confirmation
  • Operator and footer entities need clarification
  • Assigned clinician and pharmacy not established
  • Telephone support marked coming soon

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard